Date of Agreement: November 24, 2009 Customer Name: Fresenius USA Marketing, Inc. (“Customer”) Street Address of Customer: 920 Winter Street City, State, Zip of Customer: Waltham, MA 02451 Customer Contact and Phone No.: Jim Loendorf Senior Director,...Outpatient Therapy Agreement • May 8th, 2014 • NxStage Medical, Inc. • Electromedical & electrotherapeutic apparatus • Alaska
The following general terms and conditions apply to the purchase of the NxStage System One (“System”), consisting of either a Cycler, Warmer and Stand, or a Cycler and PureFlow SL (Cabinet and Control Unit), as the case may be, System cartridges and fluids (“Supplies”), and related products and services for use in chronic outpatient therapy (“Related Products”). The System, Supplies and Related Products sold hereunder are referred to collectively as “Products”.
THIRD AMENDMENT TO EXTRACORPOREAL DISPOSABLES DISTRIBUTION AGREEMENTExtracorporeal Disposables Distribution Agreement • May 8th, 2014 • NxStage Medical, Inc. • Electromedical & electrotherapeutic apparatus
This Third Amendment to the Extracorporeal Disposables Distribution Agreement (“Third Amendment”) dated January 2, 2014 (“Third Amendment Effective Date”) is made by and between Gambro Renal Products, Inc., a Colorado corporation with offices at 14143 Denver West Parkway, Lakewood, Colorado 80401 (together with its affiliates, including without limitation Baxter International Inc., “Gambro”) and NxStage Medical, Inc., a Delaware corporation with offices at 350 Merrimack Street, Lawrence, Massachusetts 01843 (together with its affiliates, “NxStage”). For the sake of clarity, Gambro’s affiliates shall include Baxter International Inc. and all of its affiliates.
NxStage Medical, Inc. Performance Share Plan Restricted Stock Unit Agreement Granted Under 2005 Stock Incentive PlanRestricted Stock Unit Agreement • May 8th, 2014 • NxStage Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
AGREEMENT made this day of (the “Grant Date”), between NxStage Medical, Inc., a Delaware corporation (the “Company”), and (the “Participant”).
